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Evidence for Involvement of Both IKCa and SKCa Channels in
Hyperpolarizing Responses of the Rat Middle Cerebral Artery
Alister J. McNeish, PhD; Shaun L. Sandow, PhD; Craig B. Neylon, PhD; Mark X. Chen, PhD;
Kim A. Dora, PhD; Christopher J. Garland, PhD
Background and Purpose—Endothelium-derived hyperpolarizing factor responses in the rat middle cerebral artery are
blocked by inhibiting IKCa channels alone, contrasting with peripheral vessels where block of both IKCa and SKCa is
required. As the contribution of IKCa and SKCa to endothelium-dependent hyperpolarization differs in peripheral arteries,
depending on the level of arterial constriction, we investigated the possibility that SKCa might contribute to equivalent
hyperpolarization in cerebral arteries under certain conditions.
Methods—Rat middle cerebral arteries (175 m) were mounted in a wire myograph. The effect of KCa channel blockers
on endothelium-dependent responses to the protease-activated receptor 2 agonist, SLIGRL (20 mol/L), were then
assessed as simultaneous changes in tension and membrane potential. These data were correlated with the distribution
of arterial KCa channels revealed with immunohistochemistry.
Results—SLIGRL hyperpolarized and relaxed cerebral arteries undergoing variable levels of stretch-induced tone. The
relaxation was unaffected by specific inhibitors of IKCa (TRAM-34, 1 mol/L) or SKCa (apamin, 50 nmol/L) alone or
in combination. In contrast, the associated smooth-muscle hyperpolarization was inhibited, but only with these blockers
in combination. Blocking nitric oxide synthase (NOS) or guanylyl cyclase evoked smooth-muscle depolarization and
constriction, with both hyperpolarization and relaxation to SLIGRL being abolished by TRAM-34 alone, whereas
apamin had no effect. Immunolabeling showed SKCa and IKCa within the endothelium.
Conclusions—In the absence of NO, IKCa underpins endothelium-dependent hyperpolarization and relaxation in cerebral
arteries. However, when NOS is active SKCa contributes to hyperpolarization, whatever the extent of background
contraction. These changes may have relevance in vascular disease states where NO release is compromised and when
the levels of SKCa expression may be altered. (Stroke. 2006;37:000-000.)
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The cerebrovascular circulation has distinct characteristicscompared with many other peripheral vessels. For exam-
ple, blockade of endothelial cell IKCa channels alone is
sufficient to block endothelium-derived hyperpolarizing fac-
tor (EDHF)–mediated relaxation and hyperpolarization in rat
middle cerebral arteries.1,2 This is a dramatic contrast to other
peripheral vessels, where in general EDHF–mediated re-
sponses are abolished by combined inhibition of both SKCa
and IKCa in the endothelium.3
In arteries where blockade of EDHF–mediated responses
require the simultaneous block of SKCa and IKCa, such as
porcine coronary and rat mesenteric arteries, functional,
electrophysiological and immunohistochemical data demon-
strate that these channels are clearly expressed only within
the endothelium.4–6 Therefore, the critical role of IKCa chan-
nels in cerebral vessels may reflect a differential expression
of KCa subtypes. In middle cerebral arteries, for example,
SKCa subunits may be absent, have a low expression level, or
perhaps be masked by high IKCa expression levels. Alterna-
tively, the cellular location of the KCa subtypes may differ
between the endothelium and the smooth muscle. However,
there is currently little evidence on the relative expression and
cellular distribution of SKCa and IKCa in rat middle cerebral
arteries, although functional data does suggest that IKCa are
localized to endothelial cells.1
The apparent dominant role of IKCa in EDHF responses in
the middle cerebral artery may reflect experimental parame-
ters. IKCa and SKCa mediate individual components of endo-
thelium-dependent hyperpolarization in rat mesenteric arter-
ies. SKCa underpin smooth-muscle hyperpolarization, whereas
IKCa reverse agonist-induced depolarization-repolarization.7
Thus, the extent of vasoconstrictor stimuli influences the
relative contribution of IKCa and SKCa for subsequent changes
in membrane potential, so that when the smooth-muscle cells
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are depolarized and constricted by 1 stimulation (with phenyl-
ephrine), block of endothelium-dependent hyperpolarization and
relaxation requires inhibition of endothelial SKCa and IKCa. What
is not known is whether a similar profile operates during the
spontaneous smooth-muscle depolarization and contraction of
myogenically active arteries under physiological pressures, such
as those in the cerebral circulation.8 For example, in rat posterior
cerebral artery mounted at 10 mm Hg, smooth-muscle cell
resting membrane potential is 67 mV, whereas after devel-
oping myogenic tone at 60 mm Hg the membrane potential is
38 mV.9 Inhibition of nitric oxide synthase (NOS) in
cerebral arteries will often constrict and depolarize the smooth
muscle further.2,10–12 The observation that EDHF in rat middle
cerebral artery is solely dependent on IKCa might reflect some
physiological masking of SKCa function rather than a lack of
expression of these channels.
The aim of the present study was to assess smooth-muscle
relaxation and hyperpolarization evoked by stimulating the
endothelium with SLIGRL, under variable levels of stretch to
mimic variable intraluminal pressures, to reveal possible
input from SKCa and define any modulation by endothelium-
derived NO in the rat middle cerebral artery. Furthermore,
using immunohistochemistry we investigated the expression
and distribution of KCa subtypes in this artery to correlate with
the functional data. Additionally, electron microscopy was
used to examine the anatomy and coupling characteristics in
the middle cerebral artery.
Materials and Methods
Whole brain from male Wistar rats (200 to 300 g; Charles River) was
removed and stored immediately in ice-cold Krebs solution. Seg-
ments of the middle cerebral artery (2 mm long) were dissected
and stored in ice-cold Krebs for use within 30 minutes. The same
size vessels were used in all experimental groups after dissection by
the same person.
Experimental Protocols for Isometric Tension and
Membrane Potential Recordings
Segments of middle cerebral artery (internal diameter 150 m)
were mounted in a Mulvany-Halpern myograph (model 400A,
Danish Myotechnology) in Krebs solution containing (mmol/L):
NaCl, 118.0, NaCO3, 24; KCl, 3.6; MgSO4  7H2O, 1.2; glucose,
11.0; CaCl2, 2.5; gassed with 95% O2 and 5% CO2 and maintained at
37°C. After equilibration for 20 minutes vessels were tensioned to 1
mN (approximates wall tension at 60 mm Hg). In some experiments
vessel tension was increased to 4 mN (approximates wall tension at
140 mm Hg) in order to increase spontaneous myogenic constric-
tion13 Smooth-muscle tension was recorded with an isometric
pressure transducer and Powerlab software (ADI, Australia). Vessel
viability was assessed by adding exogenous K (15 to 55 mmol/L,
total K concentration), vessels with tension of 3 mN being used.
Endothelial cell viability was taken as the ability of SLIGRL
(20 mol/L) to relax myogenic tone and hyperpolarize the mem-
brane by 15 mV. In some experiments, endothelial cells were
removed by gently rubbing the luminal surface with a hair.
Vasodilator responses to SLIGRL (20 mol/L) were also elicited in the
presence of KCa blockers. In 1 group of experiments, EDHF responses to
SLIGRL were recorded in the presence of L-NAME (NG-nitro-L-arginine
methyl ester) to block NOS. The additional inhibition of cyclo-oxygenase
has no effect in this artery.2 Papaverine (150 mol/L) was added at the end
of each experiment to assess overall tone. All drugs were allowed to
equilibrate for at least 20 minutes before vasodilator responses were
stimulated. In most experiments smooth-muscle tension and membrane
potential (Em) were measured simultaneously as previously described,14
using glass microelectrodes (filled with 2 mol/L KCl; tip resistance, 80 to
120 mol/L) to measure Em change.
Electron Microscopy
Anesthetized rats were perfusion-fixed using standard procedures.15
Briefly, animals were perfused via the left ventricle with a clearing
solution of 0.1% bovine serum albumin (Sigma; St Louis, Mo; A3059)
or normal donkey serum (Sigma; St Louis, Mo; D9663), 30 nmol/L
NONOate or 0.1% NaNO3 and 10 U/mL heparin, and then perfuse-fixed
with 1% paraformaldehyde, 3% glutaraldehyde in 0.1 mol/L sodium
cacodylate, with 35 mmol/L betaine (Sigma, B2629), pH 7.4. Segments
of the middle cerebral artery were removed and processed for electron
microscopy as previously described.15 Transverse sections (100 nm
thick) were cut and myoendothelial gap junctions and surrounding
endothelial cell and smooth-muscle cell regions photographed at
10 000 to 40 000 using a transmission electron microscope.
Immunohistochemistry
After perfusion fixation (as above), segments of middle cerebral
artery were dissected into PBS, cut along the lateral plane and pinned
out flat with either the intima or adventitia uppermost. Whole mount
tissues were subsequently processed using standard immunohisto-
chemical procedures.15 Briefly, after washing in PBS and incubation
(1 hour) in blocking buffer (1% normal donkey serum, or bovine
serum albumin and 0.1% Tween-20) vessels were incubated in
primary antibody overnight at room temperature. These were: SK2
(dilution, 1:100; Alomone, APC-028), SK3 (1:100; Alomone, APC-
025), SK4 (rIK1; 1:100; Alomone, APC-064), SK4 (hIK1; 1:400;
M2016) and SK4 (rIK1; 1:1500; IK38/617). Endothelial and smooth-
muscle cell layers were identified by taking successive optical
sections from the intimal or adventitial surface and by the use of
antibodies to a-actin (1:40; Sigma, A5288) and von Willebrand
factor (1:300; Sigma, F3520). Tissue was subsequently washed in
PBS and incubated in rabbit Alexa 633 (1:100; Molecular Probes;
Paisley, UK; A21071) or rabbit FITC (1:40; Sigma; St Louis, Mo;
F6005) for 2 hours at room temperature. Preparations were mounted
in buffered glycerol and images collected on a confocal microscope.
Data for each vessel was from 3 to 6 animals.
Controls for antibody specificity included omission of the
primary antibody, substitution of the primary antibody for an
unrelated rabbit IgG (1:100; Chemicon; Temecula, Calif; PP64),
incubation in fluorophore alone and preincubation with a 10-fold
excess of peptide (when available) to which the antibody was
raised. Additionally, the specificity of the antibodies used has
been previously demonstrated using Western blotting and immu-
nostaining of transfected cells4,16 –19 (supplemental Figure I,
available online at http://stroke.ahajournals.org).
Solutions and Drugs
Exogenous K was added as an isotonic physiological salt solution
in which all the NaCl was replaced with an equivalent amount of
KCl. Concentrations of K used are expressed as final bath concen-
tration, unless specifically stated. Glibenclamide, L-NAME, ouabain,
and papaverine HCl were all obtained from Sigma. Apamin and
iberotoxin, from Latoxan. ODQ (1H-(1,2,4)oxadiazolo(4,3-
a)quinoxalin-1-one) from Tocris. SLIGRL from Auspep. DEA-
NONOate from Alexis. TRAM-34 was a generous gift from H.
Wulff (University of California, Davis). All stock solutions were
prepared in distilled water except ODQ and TRAM-34 (10 mmol/L),
which were dissolved in dimethylsulfoxide (DMSO).
Statistical Analysis
Results are expressed as the meanSE mean of n animals. Tension
values are in mN (always per 2 mm segment) and Em as mV.
Vasodilatation is expressed as percentage reduction of the total
vascular tone (myogenic tone plus vasoconstrictor response) as-
sessed by relaxation to papaverine (150 mol/L). Graphs were
drawn and comparisons made using 1-way ANOVA with Bonferroni
post-test (Prism, Graphpad). P0.05 was considered significant.
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Results
Isometric Tension and Smooth-Muscle Cell
Membrane Potential Recordings
Rat middle cerebral arteries spontaneously developed myogenic
tone equivalent to 14.05.9% (n6) of the maximum arterial
constriction (6.70.5 mN, n7), at which the resting membrane
potential was 48.01.2 mV (n5). Addition of the protease-
activated receptor 2 agonist, SLIGRL (20 mol/L) evoked
relaxation and smooth-muscle cell hyperpolarization
(89.010.7% and 18.22.7 mV, respectively, n11). Both
responses were completely unaffected by either apamin (50
nmol/L; SKCa blocker), or TRAM-34 (1 mol/L; IKCa blocker;
Figures 1 and 3. However, the combined presence of apamin and
TRAM-34 virtually abolished the SLIGRL-induced (EDHF-
mediated) hyperpolarization without modifying relaxation be-
cause the NO component of the SLIGRL response was still able
to elicit maximal relaxation (Figures 1 and 3). The level of
myogenic tone was unaffected by apamin and TRAM-34. A
similar profile was recorded in vessels where tension was
increased to 4 mN (70% of the maximum tension), where
relaxation and hyperpolarization evoked by SLIGRL was
77.01.3% and 20.23.1 mV, respectively (n9; Figure 3).
The relaxation was still unaffected by either apamin, TRAM-34
or the combined application of these drugs, whereas in contrast
hyperpolarization to SLIGRL was attenuated by TRAM-34 and
apamin in combination (10.51.8 mV, n9; Figures 2 and 3).
In the presence of L-NAME, SLIGRL (20 mol/L) evoked
EDHF-mediated relaxation and hyperpolarization (Figure 3).2
Alone, L-NAME (100 mol/L) evoked smooth-muscle depo-
larization (12.80.7 mV, n4) and associated constriction
(2.80.4 mN, n4). Removal of the endothelium similarly
depolarized (to 35.63.4 mV, n3) and constricted
(1.70.2 mN, n7) arteries. In these arteries, L-NAME did
not cause further constriction (0.10.0 mN, n5), and
SLIGRL failed to evoke relaxation. In endothelium-intact
vessels, relaxation and hyperpolarization to SLIGRL in the
presence of L-NAME were completely abolished by
TRAM-34 alone (Figure 3), and apamin had no effect.2
The soluble guanylate cyclase inhibitor ODQ (10 mol/L)
had a similar effect to L-NAME in that it depolarized (to
35.56 mV, n3) and constricted (	tension3.80.7
mN, n3) arteries. As with the L-NAME effect, SLIGRL-
induced relaxation (73.56.2%, n6) was sensitive to
TRAM-34 alone (20.33.6%, n6), and apamin had no
further effect (15.05.9%, n3).
In an attempt to identify the mechanism for activation of
SKCa by SLIGRL in the presence of NO, a direct action of the
NO donor DEA-NONOate (300 nmol/L) was investigated in
arteries at normal tension in the absence and presence of
L-NAME. In the absence of L-NAME, 300 nM DEA-
NONOate hyperpolarized smooth-muscle cells by
11.61.5 mV (n6), which was unaltered by apamin
(14.4.4 mV, n4). Similarly, in the presence of
L-NAME, DEA-NONOate again stimulated hyperpolariza-
tion (12.21.2 mV, n11), yet apamin and TRAM-34
were without effect (Figure 4). NO can cause smooth-muscle
hyperpolarization by activating either KATP or BKCa channels.
Glibenclamide (block of KATP) had no significant effect on
DEA-NONOate-induced hyperpolarization, whereas hyper-
polarization was sensitive to block with iberotoxin (block of
BKCa; to 4.31.6 mV, n4; P
0.05). None of these
treatments affected the relaxation to DEA-NONOate (Figure
4). Furthermore, ODQ had no significant effect on DEA-
NONOate-induced hyperpolarization (8.43.5 mV, n6),
but significantly inhibited relaxation (15.79.5%, n7;
P
0.05; Figure 4).
Figure 2. Effect of KCa channel inhibitors on
responses to 20 mol/L SLIGRL in rat middle
cerebral arteries at high stretch-induced tension
(4 mN). Traces of simultaneous recording of
smooth-muscle membrane potential (top) and ten-
sion (bottom) under control conditions (a) and in
the presence of TRAM-34 (1 mol/L; b) or
TRAM-34 and apamin (50 nmol/L; c), recorded
from the same artery. Dashed lines correspond to
50 mV and 2 mN.
Figure 1. Effect of KCa channel inhibitors on responses to
20 mol/L SLIGRL in rat middle cerebral arteries at normal ten-
sion (1 mN). Traces of simultaneous recording of smooth-
muscle membrane potential (top) and tension (bottom) in rat
middle cerebral arteries under control conditions (a) and in the
presence of TRAM-34 (1 mol/L; b) or TRAM-34 and apamin
(50 nmol/L; c), recorded from the same artery. Dashed lines cor-
respond to 45 mV and 2 mN.
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Morphology and KCa Expression in the Rat Middle
Cerebral Artery
Middle cerebral arteries comprised 3 to 4 smooth-muscle cell
layers and contained homo- and heterocellular gap junctions.
Adjacent endothelial cells were coupled by large gap junctional
plaques, whereas junctions between adjacent smooth-muscle
cells or between smooth-muscle and endothelial cells (myoen-
dothelial gap junctions) were relatively small (Figure 5). The
latter were on a bulbous enlargement (1.2 m across) at the
end of a thin stalk (100 nm) projecting from an endothelial cell
through the internal elastic lamina (Figure 5).
Positive staining for SK2 (KCa2.2), SK3 (KCa2.3) and IK1
(KCa3.1) was observed (Figure 6), with SK2 (mainly perinuclear
location) and SK3 (low-level punctate staining on or near the
plasmalemma) being restricted to the endothelium and IK1 present
on both endothelial and smooth-muscle cells (plasmalemma and
cytoplasmic location). The characteristics of IK staining were the
same with each of 3 different IK channel antibodies.
Discussion
We demonstrate that SKCa can contribute to endothelium-
dependent hyperpolarization in the rat middle cerebral artery, but
only when the vessels are able to synthesize NO. Furthermore,
the contribution from SKCa was not dependent on the level of
prior arterial constriction. In contrast, when either endothelial
NOS or soluble guanylyl cyclase were inhibited, IKCa alone
underpined endothelium-dependent hyperpolarization and the
associated relaxation, as previously reported.1,2 We also show,
using immunohistochemistry, that both SKCa and IKCa are
present on endothelial cells in the middle cerebral artery. In order
to record membrane potential in isobaric preparations, pharma-
cological interventions, such as the addition of nifedipine, are
required and prevent simultaneous measurement of the dilator
response. Therefore, all experiments were conducted in a wire
myograph to enable simultaneous recording of changes in
smooth-muscle tension and smooth-muscle membrane potential.
We have previously compared the EDHF response under iso-
metric and isobaric conditions and found no major differences
with SLIRL–induced dilator responses.2
It is unclear why SKCa channels do not contribute to
hyperpolarization when NOS is inhibited in the rat middle
cerebral artery. However, this is in contrast to the rat
mesenteric artery.7 In quiescent mesenteric artery, EDHF
Figure 3. Summary of the effect of KCa channel inhibitors on responses to 20 mol/L SLIGRL in rat middle cerebral arteries at different
background tensions. Average paired hyperpolarization (top) and relaxation (bottom) responses stimulated by SLIGRL in arteries
stretched to normal tension (1 mN; a), high tension (4 mN; b) or normal tension in the presence of L-NAME–induced vasoconstriction (c)
under control conditions or in the presence of either apamin (50 nmol/L), TRAM-34 (1 mol/L) or their combination. *P0.05 indicates a
significant difference from control, n3.
Figure 4. Summary of the effect of inhibitors
on responses to 300 nM DEA-NONOate in
rat middle cerebral arteries at normal ten-
sion in the presence of L-NAME–induced
vasoconstriction. Average paired hyperpo-
larization (A) and relaxation (B) responses
stimulated by DEA-NONOate under control
conditions and in the presence of either
TRAM-34 (1 mol/L), apamin (50 nmol/L),
iberiotoxin (IbTx, 100 nmol/L), ODQ
(10 mol/L), or glibenclamide (10 mol/L).
*P
0.05 indicates a significant difference
from control, n4.
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hyperpolarization is almost totally attributable to SKCa activ-
ity
,
whereas during vasoconstriction with phenylephrine this
changes, so both SKCa and IKCa contribute to the EDHF
response. Thus, at least in the mesenteric artery, the extent of
arterial stimulation can alter the contribution of IKCa and SKCa
to endothelium-dependent hyperpolarization. This is clearly
not the case in the middle cerebral artery, as IKCa contributed
to endothelium-dependent hyperpolarization over a range of
tensions equal to or greater than observed in the presence of
L-NAME, when SKCa activity was not detected.
An alternative explanation could be that NO, or an asso-
ciated reactive oxygen species, facilitates SKCa activation. NO
donors have been shown to stimulate SKCa in rat fundus by a
cGMP–dependent mechanism.20 However, in the rat middle
cerebral artery, either in the absence or presence of L-NAME,
hyperpolarization produced by addition of an NO donor
(DEA-NONOate) was unaffected by inhibition of SKCa, but
was inhibited by blockade of BKCa. Thus, a direct effect of
NO on SKCa seems unlikely, although an additive effect
perhaps requiring rises in intracellular Ca2 at sites near the
SKCa channels cannot be excluded. Another possibility is that
NO may indirectly activate SKCa, possibly through inhibition
of cytochrome P450–dependent enzymes.21 In cerebral arter-
ies, cytochrome P450, via the hydroxylase pathway, produces
20-HETE, a mediator involved in development of myogenic
constriction, at least in part, attributable to inhibition of BKCa
channels.22 Thus, removing an inhibitory influence of NOS
may increase 20-HETE, with consequent vasoconstriction.
An effect of this kind would be consistent with the L-NAME–
induced vasoconstriction and depolarization we observed.
However, there is currently no evidence that 20-HETE or
other cytochrome P450 metabolites might inhibit SKCa.
Another possibility relates to the ultrastructural and morpho-
logical characterization of the arterial cells and KCa channels.
Throughout this study, we used the same sized vessels (diameter
175 mol/L), taken from the second branch of the middle
cerebral artery, because we found there to be no significant
difference in relaxation responses to SLIGRL compared with
either a larger or smaller branch (data not shown). In this branch
of the middle cerebral artery, interendothelial cell and
intersmooth-muscle cell gap junctions could be observed, and in
addition myoendothelial gap junctions were present suggesting
that both homo- and heterocellular coupling exists between the
different cell types; these findings are similar to those described
in human cerebral arteries.23 Because both IKCa and SKCa were
expressed in the endothelium, and SLIGRL stimulates an endo-
thelium-dependent response through a receptor coupled by Gq/11
to rises in intracellular Ca2, the likely explanation is that
endothelial cell hyperpolarization may be transmitted to the
muscle layers through myoendothelial gap junctions. However,
it appears that when considering nonnuclear staining, both the
SK2 and SK3 channels are very diffuse within the endothelium,
suggesting low levels of expression. Therefore, it is possible that
Figure 5. Ultrastructural morphology of rat middle cerebral
artery. Three to 4 smooth-muscle cell (SMC) layers (A) with typi-
cal gap junction morphology (B through D) were present in the
vessel wall. Gap junctions between adjacent endothelial cells
(EC) were generally large (B and inset), whereas those between
adjacent smooth-muscle cells (C and inset) and adjacent endo-
thelial and smooth-muscle cells were typically small (D and
insets). These latter myoendothelial gap junctions were present
on EC derived projections with a thin (100 nm wide) stalk
passing through the internal elastic lamina (IEL) with a bulbous
enlargement at the EC-SMC interface (asterisk; 1.2 m at the
widest point; D and D, lower inset). The lower inset in D shows
a section with a pentalaminar structure (upper inset) character-
istic of a gap junction 4 serial sections (400 nm) past that
shown in D (main panel). Bar, A, 5 m; B through D, 0.5 m; B,
C, insets, 50 nm; D, upper inset, 25 nm; D, lower inset, 1 m.
Figure 6. En face view of endothelial cell (EC; green) and smooth-
muscle cell (SMC; red) Ca2-activated K channel (KCa) expression in
the middle cerebral artery. Diffuse high level expression of SK2
(KCa2.2) was confined mainly to endothelial cell nuclei (A), as opposed
to the muscle (A, inset). Counterstaining with propridium iodide con-
firmed nuclear staining with SK2 in A (data not shown). Punctate low
level expression of SK3 (KCa2.3) was confined to the endothelium (B,
arrows) and absent in the muscle (B, upper inset). A positive control
comparison is shown in the endothelium of a saphenous artery taken
from a juvenile rat (B, lower inset) N.B. The diffuse background green
staining with ridge-like pattern represents the autofluorescence of the
internal elastic lamina and not specific SK3 staining. Punctate and
diffuse high level expression of IK (KCa3.1), which was predominant at
or near the plasmalemma, and also at a low level near cell nuclei, was
present in both endothelial (C) and smooth-muscle cells (D). Expres-
sion of IK was additionally observed in the cytoplasm of smooth mus-
cle cells along lines parallel to the long axis of the cells (D, paired
arrows). High level punctate and lower level diffuse expression of BK
was present at or near the plasmalemma in smooth-muscle cells (E),
but not endothelial cells (E, inset). The ability to label endothelial cells
was confirmed with vWF (F, upper inset). The autofluorescence of the
internal elastic lamina (IEL, F, lower inset) was clearly observed, and
served to separate the endothelial and smooth-muscle layers when
obtaining optical sections through the tissue z-axis. The longitudinal
vessel axis runs horizontally in all panels (cell orientation indicated in
F). Bar, 50 m.
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their contribution to functional responses is less marked than
through IKCa channels, which had a more uniform distribution.
This is in marked contrast to the high expression levels of SK3
at adjacent endothelial cell borders in porcine coronary artery,4
and juvenile rat saphenous artery (Figure 6), arteries which
exhibit an EDHF response that is clearly dependent on the
activation of both SKCa and IKCa.4,15,24
IKCa expression was observed in both the endothelial and
smooth-muscle cells. The endothelial cell expression was asso-
ciated with the plasma membrane, consistent with the role of
IKCa in endothelium-dependent hyperpolarization. This is similar
to functional data for this channel obtained in porcine coronary,5
rat mesenteric6 and rat middle cerebral arteries.1 Evidence for
expression of IKCa in the smooth muscle was unexpected and
contrasted to its absence from smooth muscle in the rat mesen-
teric artery using the same protocols (S.L.S. and C.J.G., unpub-
lished results, 2005). Smooth muscle staining for IKCa was
apparent both at the plasmalemma and within the cytoplasm.
The veracity of our data regarding IKCa expression in the middle
cerebral artery is supported by the use of 3 different IKCa
(KCa3.1,16,17) antibodies. Although further investigation of a
possible functional role for muscle IKCa is called for, a tonic role
for these channels in hyperpolarizing and relaxing the smooth
muscle seems unlikely. The addition of TRAM-34 did not
stimulate any increase in arterial tone,2 which would be pre-
dicted when smooth-muscle Ca2 levels were elevated in asso-
ciation with myogenic tone.
In summary, when endothelial NOS is inhibited, IKCa activity
alone can explain EDHF–mediated hyperpolarization and relax-
ation in middle cerebral arteries. When the NO/cGMP pathway is
active, both SKCa and IKCa then contribute to SLIGRL–induced
hyperpolarization. Thus, functional SKCa activity can be uncovered
in the rat middle cerebral artery, although the input it makes to
hyperpolarization and relaxation does not appear marked under
normal conditions. However, sex hormones such as estrogen can
modulate the relative contribution made to vasodilatation by EDHF
and NO in the cerebral circulation,25 and estrogen can upregulate
SKCa expression.26,27 Therefore, it is likely that the importance of
SKCa differs significantly in disease states where estrogen levels are
altered or NO release is in some way compromised.
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Figure I. Validation of rabbit anti-hIK1 antibody M20. 10 g
total cell extract from untransfected and stable CHO cell lines
expressing hSK1, hSK2, hSK3 and hIK1 was loaded in each
lane. The arrow indicates the predicted size of tetrameric chan-
nel complex. The lower molecular mass bands are likely a com-
bination of degradation products or trimers, dimers and mono-
mers of the hIK1 complex.
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